Technology
A Different Approach to Creatine Delivery
Creatine monohydrate is one of the most extensively researched ingredients in sports nutrition. At Project Creatine, we explore how innovative formulation technologies can offer different approaches to delivering this established ingredient.
Our current Creatine Monohydrate Capsules feature CreaXorb™, powered by BioSNEDS technology, a specialized self-emulsifying creatine delivery system designed for creatine monohydrate.
This approach focuses on the formulation and delivery of creatine rather than simply changing the underlying ingredient. By exploring different delivery formats, Project Creatine aims to make creatine supplementation more convenient while continuing to provide clear information about the science behind its formulations.
What Is CreaXorb™?
CreaXorb™ is a specialized creatine formulation incorporating BioSNEDS delivery technology. Unlike conventional creatine monohydrate powder, CreaXorb™ uses a lipid-based, self-emulsifying formulation designed to disperse during digestion.
This allows Project Creatine to offer creatine monohydrate in a convenient capsule format using a differentiated delivery approach.
How Does BioSNEDS Technology Work?
BioSNEDS uses a self-emulsifying delivery system designed to disperse when exposed to gastrointestinal fluids.
How Does BioSNEDS Technology Work?
BioSNEDS uses a self-emulsifying delivery system designed to disperse when exposed to gastrointestinal fluids.
The process involves three key steps:
1. Formulation
Creatine monohydrate is incorporated into a specialized delivery matrix.
2. Dispersion
During digestion, the formulation is designed to disperse into fine droplets.
3. Systemic Exposure
The delivery system is designed to influence how creatine becomes available for absorption. Pharmacokinetic research can help evaluate this process by measuring creatine concentrations in blood over time.
What Does the Research Show?
Human pharmacokinetic research has investigated creatine delivered using CreaXorb™ and BioSNEDS technology.
The research evaluated systemic creatine exposure following supplementation and reported differences compared with conventional creatine monohydrate under the study conditions.
An Important Scientific Distinction
Systemic creatine exposure is not the same as muscle creatine uptake or demonstrated improvements in strength, recovery, or cognitive performance.
Pharmacokinetic findings help researchers understand formulation and delivery characteristics, but they do not independently establish superior functional outcomes.
For consumers interested in how to improve creatine absorption, it is important to distinguish research on systemic exposure from evidence demonstrating functional outcomes.
The Project Creatine Approach
Project Creatine combines established creatine monohydrate research with thoughtful formulation and convenient product formats. CreaXorb™ and BioSNEDS represent the delivery technology used in our current Creatine Monohydrate Capsules. Other Project Creatine formulations may use different ingredients and delivery approaches.
Our focus remains simple: creatine science, thoughtful innovation, and transparent product information. A clean formulation also starts with clear ingredient information and transparency about how a product is formulated and delivered.
We believe consumers should be able to understand not only what they are taking, but also how a product is formulated and what the available research actually demonstrates. Our approach is to communicate formulation details clearly, distinguish research findings from broader assumptions, and continue exploring practical approaches to nutrient delivery. This helps keep innovation grounded in evidence while giving consumers clearer information when evaluating different creatine products and delivery formats.
